Your browser doesn't support javascript.
loading
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.
Shi, Yuankai; Hu, Xingsheng; Zhang, Shucai; Lv, Dongqing; Wu, Lin; Yu, Qitao; Zhang, Yiping; Liu, Li; Wang, Xiang; Cheng, Ying; Ma, Zhiyong; Niu, Hongrui; Wang, Dong; Feng, Jifeng; Huang, Cheng; Liu, Chunling; Zhao, Hui; Li, Jingzhang; Zhang, Xiaodong; Jiang, Yong; Gu, Chuan.
Afiliación
  • Shi Y; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center and National Clinical Research Center for Cancer and Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Electr
  • Hu X; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center and National Clinical Research Center for Cancer and Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Zhang S; Department of Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Oncology Institute, Beijing, China.
  • Lv D; Department of Respiratory, Taizhou Hospital of Zhejiang Province, Taizhou, China.
  • Wu L; Thoracic Medicine Department II, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Yu Q; Department of Medical Oncology of Respiratory, Guangxi Medical University Affiliated Tumor Hospital, Nanning, China.
  • Zhang Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
  • Liu L; Department of Thoracic Oncology, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang X; Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou, China.
  • Cheng Y; Jilin Cancer Hospital, Changchun, China.
  • Ma Z; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Niu H; Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
  • Wang D; Department of Oncology, Daping Hospital, Chongqing, China.
  • Feng J; Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.
  • Huang C; Fujian Cancer Hospital, Fuzhou, China.
  • Liu C; Cancer Hospital of Xinjiang Medical University, Urumqi, China.
  • Zhao H; The Second Hospital Of Anhui University, Hefei, China.
  • Li J; Liuzhou People's Hospital, Liuzhou, China.
  • Zhang X; Department of Medical Oncology, Nantong Cancer Hospital, Nantong, China.
  • Jiang Y; Shanghai Allist Pharmaceutical Technology, Shanghai, China.
  • Gu C; Shanghai Allist Pharmaceutical Technology, Shanghai, China.
Lancet Respir Med ; 9(8): 829-839, 2021 08.
Article en En | MEDLINE | ID: mdl-33780662
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridinas / Pirimidinas / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Indoles / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Lancet Respir Med Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridinas / Pirimidinas / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Indoles / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Lancet Respir Med Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido